# Pathcision Medicine, Inc.

Canonical: https://abierto.us/vendors/pathcision-medicine-inc-ck6qrf2glbt1

- UEI: CK6QRF2GLBT1
- CAGE: 9BD69
- Location: Watertown, MA
- Awards in window: 1 (2 transactions), $299,981 obligated, August 5, 2025 to July 20, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $299,981

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $299,981

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Solicitations won

- National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program – Fiscal Year 2025 (75N91024R00013). https://abierto.us/opportunities/75n91024r00013

## Largest awards

- 75N91025C00018 (definitive contract): $299,981, NIH NCI. SBIR Concept Award for a Novel Delivery Approach to Transform Metastatic Pancreatic Cancer Treatment and Prevention. https://www.usaspending.gov/award/CONT_AWD_75N91025C00018_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/pathcision-medicine-inc-ck6qrf2glbt1.